Development of cloning-free protocols for generation of gene knockouts using CRISPR-Cas9 technology in the model organisms Danio rerio Drosophila melanogaster and Mus Musculus by Craveiro, Catarina Filipe da Costa
i 
 
  
                                   INSTITUTO POLITÉCNICO DE LISBOA 
 
     Instituto Superior de Engenharia de Lisboa 
     Escola Superior de Tecnologia da Saúde de Lisboa 
 
 
 
 
 
 
 
 
 
 
 
 
Development of cloning-free protocols for generation of gene knockouts using 
CRISPR-Cas9 technology in the model organisms Danio rerio,  
Drosophila melanogaster and Mus musculus 
 
Catarina Filipe da Costa Craveiro 
Trabalho Final de Mestrado para obtenção do grau de Mestre em Engenharia Biomédica 
 
Orientadores 
Ana Catarina Certal (Fundação Champalimaud) 
Isabel Campos (Fundação Champalimaud) 
Cecília R.C. Calado (ISEL- Instituto Superior de Engenharia de Lisboa) 
 
 
 Outubro de 2017 
  
 
 
 
 
  
 
INSTITUTO POLITÉCNICO DE LISBOA 
 
 
Instituto Superior de Engenharia de Lisboa 
Escola Superior de Tecnologia da Saúde de Lisboa 
  
     
 
 
 
 
 
 
 
Development of cloning-free protocols for generation of gene knockouts using 
CRISPR-Cas9 technology in the model organisms Danio rerio,  
Drosophila melanogaster and Mus musculus 
 
Catarina Filipe da Costa Craveiro 
Trabalho Final de Mestrado para obtenção do grau de Mestre em Engenharia Biomédica 
Orientadores 
Ana Catarina Certal (Fundação Champalimaud) 
Isabel Campos (Fundação Champalimaud) 
Cecília R.C. Calado (ISEL- Instituto Superior de Engenharia de Lisboa) 
 
Júri 
Presidente: Manuel Matos (ISEL- Instituto Superior de Engenharia de Lisboa) 
Vogais: Rita Aires ( Instituto Gulbenkian Ciência) 
                        Ana Catarina Certal (Fundação Champalimaud) 
 
Outubro de 2017 
ii 
 
Agradecimentos 
 
        Gostaria de agradecer às minhas orientadoras principais, Ana Catarina Certal e Isabel Campos 
pela oportunidade que me derem para realizar este projeto assim como a confiança que depositaram 
em mim para obter resultados. Foram o grande alicerce de todo o meu projeto e estiveram sempre 
disponíveis para colmatar todas as minhas dúvidas.  
        À minha coorientadora Cecília Calado pelas informações institucionais e também pelo apoio total 
na elaboração desta tese, mostrando-se também sempre disponível para qualquer questão. 
        À minha colega Joana Monteiro que se disponibilizou a acompanhar-me na fase inicial deste 
projeto, nomeadamente em questões relativas à Biologia Molecular, ensinando-me muitas das técnicas 
aqui aplicadas.  
        À minha colega Sofia Silva por toda a ajuda relativa aos cruzamentos de moscas, assim como 
toda a equipa da Fly Platform que também sempre me deu o seu apoio e tempo para qualquer questão.  
         À Plataforma de Biologia Molecular da FC, nomeadamente Ana Cunha e Raquel Tomás, por 
toda a ajuda e esclarecimento de dúvidas. 
        Às minhas colegas Andreia Madalena e Natacha Leonardo por serem as colegas mais 
empenhadas em quererem o resultado positivo deste projeto e também por toda a ajuda delas em 
questões como recolhas de amostras, superovulação de fêmeas, e muito mais.  
        Às minhas colegas de faculdade, que apesar de não estarem dentro da engenharia genética se 
disponibilizaram na ajuda à elaboração desta dissertação.  
         E por último, ao meu namorado e aos meus pais por todo o apoio, foram essenciais.  
 
 
 
  
iii 
 
 
 
 
 
 
 
 
 
 
 
Development of cloning-free protocols for generation of gene knockouts using 
CRISPR-Cas9 technology in the model organisms Danio rerio,  
Drosophila melanogaster and Mus musculus. 
 
 
 
 
Catarina Filipe da Costa Craveiro 
 
2017 
 
 
This thesis was fully performed at Fish Facility, Fly Facility and Vivarium at 
Champalimaud Foundation under the direct supervision of Ana Catarina Certal and Isabel 
Campos, in the scope of the Master Thesis in Biomedical Engineering of the ISEL-Instituto 
Superior de Engenharia de Lisboa and ESTeSL-Escola Superior de Tecnologia da Saúde de 
Lisboa.  
iv 
 
Index 
 
Agradecimentos ..................................................................................................................................ii 
List of Abbreviations ............................................................................................................................ v 
Resumo ............................................................................................................................................... 1 
Abstract .............................................................................................................................................. 4 
1. Introduction.................................................................................................................................... 5 
1.1. Model organisms and their manipulation to produce knockouts ......................................... 5 
1.2. Bacteria CRISPR adaptive immunity system ........................................................................ 14 
1.3. The tyrosinase and yellow gene ........................................................................................... 18 
2. Aims .............................................................................................................................................. 19 
3. Material and Methods.................................................................................................................. 20 
3.1 Production of guideRNA ........................................................................................................ 20 
3.2 Cas9 Protein .......................................................................................................................... 22 
4. Danio rerio (zebrafish) 
4.1 Methods  .................................................................................................................................... 23 
4.2. Results ....................................................................................................................................... 27 
5. Drosophila melanogaster (fruit fly) 
5.1  Methods .................................................................................................................................... 34 
5.2 Results ........................................................................................................................................ 35 
6. Mus musculus (mouse) 
6.1  Methods .................................................................................................................................... 40 
6.2.  Results ...................................................................................................................................... 43 
7. General discussion 
8. General conclusions ..................................................................................................................... 50 
9. Bibliography ................................................................................................................................. 51 
Appendix .......................................................................................................................................... 59 
 
 
 
 
   
  
v 
 
List of Abbreviations  
 
ADN – Ácido desoxiribonucléico 
ARN – Ácido ribonucléico 
Cas - CRISPR-associated 
CF – Champalimaud Foundation  
CRISPR - Clustered Regularly Interspaced Palindromic Repeats 
CrRNA – CRISPR RNA 
DNA – Deoxyribonucleic acid  
DSB – Double Strand Break 
EDTA - Ethylenediaminetetraacetic acid 
ES cells - Embryonic stem cells 
EtOH -  Etanol 
gRNA - guideRNA 
hCG – Human chorionic gonadotropin 
Hpf – hours post fertilization 
Hpi – hours post injection 
HR – Homologous Recombination 
KCl  - Potassium chloride 
Mgcl2 - Magnesium chloride 
MiMIC - Minos Mediated Integration Cassette 
mRNA –  messenger Ribonucleic acid  
NaOH – Sodium hydroxide 
NHEJ – Non-Homologous End Joining 
PAM - Proto-spacer adjacent motif 
PCR – Polymerase Chain Reaction 
vi 
 
PMSG – Pregnant’s mare´s serum gonadotropin 
RNA – Ribonucleic acid 
SRSRs - Short Regularly Spaced Repeats 
TracrRNA - Trans-activating RNA 
Tris -  tris(hydroxymethyl)aminomethane 
Tris-HCl - Tris hydrochloride 
Tyr - Tyrosinase 
ZNFs - Zinc Finger Nucleases
1 
 
Resumo 
 
 Charles Darwin (1809-1882) apresentou a sua teoria da evolução em 1859 quando publicou 
“Origem das Espécies por Meios de Seleção Natural ou a Preservação das Raças Favorecidas na Luta 
pela Vida” que indica que todos os seres vivos têm um ancestral comum. Esta teoria leva à conclusão 
de que a maioria das funções biológicas moleculares e celulares do organismo humano podem ser 
estudadas de uma forma mais eficiente e simples em organismos não-humanos. A utilização de 
modelos animais não humanos para determinados estudos de investigação em vez do ser humano traz 
vantagens a níveis experimentais e, principalmente, a nível ético. A experimentação animal traz 
benefícios não só ao ser humano mas também aos próprios animais. Organismos Modelo são assim 
espécies não humanas que são biologicamente estudadas na expectativa de descobrir funções de genes, 
curas para doenças ou melhorias na qualidade de saúde que podem ser aplicadas a outros organismos. 
Espécies como Danio rerio (peixe-zebra), Drosophila melanogaster (mosca-da-fruta) e Mus musculus 
(murganhos), são exemplos de animais usados como organismos modelo pela comunidade científica. 
Os murganhos por exemplo, constituem  o organismo modelo geneticamente mais semelhante ao ser 
humano, sendo cerca de 85% das regiões codificadoras dos murganhos idênticas à do ser humano, 
chegando para alguns dos genes mesmo a 99% de semelhança.  
 Apesar do genoma humano estar completamente sequenciado, para muitos genes ainda é 
desconhecida a sua função. Para estudar a função dos genes, um organismo knockout é essencial 
porque ao tornar o gene inativo permite quantificar/qualificar a consequência dessa inatividade, e daí 
inferir a função génica. Um knockout pode ser conseguido através de uma mutação no gene. A 
tecnologia de CRISPR/Cas9 é um mecanismo encontrado na resposta imunitária das bactérias, que 
tornou possível provocar mutações dirigidas a genes específicos. Para este sistema funcionar é 
necessário a proteína CRISPR associated 9 (Cas9) (para cortar o ADN), uma região proto-spacer 
adjacent motif (PAM) (região no ADN reconhecida pela proteína Cas9) e um guideRNA (que guia a 
Cas9 à região alvo). A proteína Cas9 provoca um corte na dupla cadeia de ADN e a célula tenta 
reparar esse corte através do mecanismo Non Homologous End Joining (NHEJ), mas durante este 
processo podem ocorrer várias mutações, como deleções ou inserções, provocando uma frameshift 
que, ou produz uma proteína deficiente ou impossibilita a produção da proteína - qualquer das opções 
é um knockout do gene. Não existe um protocolo de produção de guideRNA e consequente produção 
de knockouts que seja facilmente intermutável entre os 3 organismos modelo abordados neste projeto, 
sendo esse o nosso maior objectivo na elaboração deste trabalho.  
 Para alcançar o objectivo da tese foi usado um protocolo já estabelecido para produção de 
guideRNA e consequente produção de animais mutantes em peixe-zebra: primeiramente como prova 
de princípio em peixe-zebra e posteriormente em mosca-da-fruta e murganho. Depois de estabelecido 
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esse protocolo em peixe-zebra e de termos obtido animais mutantes estáveis, tentámos optimizar o 
mesmo protocolo para mosca-da-fruta e para murganho de acordo com as diferenças de 
desenvolvimento embrionário inerentes a cada organismo.  
 Para a realização deste projeto, foram escolhidos genes que provocariam um efeito 
fenotipicamente visível aquando mutados de modo a facilitar o processo de rastreamento de mutantes. 
No caso do peixe-zebra e do murganho, o gene escolhido foi tyrosinase, envolvido na produção do 
pigmento preto no corpo e nos olhos dos animais. Para a mosca-da-fruta, o gene escolhido foi o 
yellow, também envolvido na produção do pigmento acastanhado da cutícula deste insecto. Em peixe-
zebra, o gene tyrosinase foi mutado com sucesso, ficando assim inoperativo. Esta mutação causou 
mosaicismo fenotípico e genético: algumas células destes animais não tinham pigmento e confirmou-
se a presença de diversos alelos mutantes diferentes no genoma.  
 Exemplo de algumas  limitações que existiram na elaboração deste projeto foi, no protocolo de 
produção de guideRNA e produção de animais mutantes e a extração de ARN a partir do ADN 
transcrito. Para extração de ARN o protocolo utiliza o Qiagen micro-RNA extraction kit. No entanto, a 
quantidade extraída de ARN com recurso a este reagente foi diminuta. Face a estes resultados, fizemos 
uma comparação direta entre a extração de ARN com esse mesmo kit e extração com 
fenol/clorofórmio a partir do mesmo produto de transcrição. Com o fenol/clorofórmio foi possível 
extrair quase 10 vezes mais ARN do que com o kit. Após estes resultados, todos os outros guideRNAs 
foram extraídos com o método de fenol/clorofórmio.  
 Outra limitação existente no seguimento do protocolo usado neste projecto, foi a amplificação 
a partir de ADN genómico extraído de embriões com 24h de peixe-zebra. Para concluir que essa 
região do gene poderia não estar acessível no estadio de desenvolvimento de embrião de 24h, testámos 
dois factores: o protocolo de extração de ADN em embriões de 24h e os estadios de desenvolvimento 
até aos 5 dias de idade. Para testar a extração de ADN em embriões de 24h, comparámos a 
amplificação a partir de ADN genómico extraído de embriões de 24h para dois genes: tyrosinase e 
DIA1R (amplificação deste gene em embriões de 24h já tinha sido anteriormente observada) como 
controlo. Foi possível observar que para o o gene DIA1R continuava a existir amplificação do gene, ao 
contrário do gene da tyrosinase. De seguida, para testar em que estadio de desenvolvimento a 
amplificação da região pretendida do gene da tyrosinase começava a ser observada, extraímos ADN 
de embriões de 24h, larvas de 72h, larvas com 3 dias e larvas com 5 dias de idade, seguidas de reações 
de PCR para amplificação dessa mesma região. Amplificação da região pretendida do gene tyrosinase 
a partir de ADN genómico extraído de larvas de 5 dias foi observada, no entanto é uma amplificação 
muito diminuta.  
 A microinjeção em mosca-da-fruta de guideRNA in vitro ao contrário de em plasmídeo, apesar 
de ter sido mostrado por outros investigadores, ser mais eficiente, leva a um processo de produção de 
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guideRNA mais dispendioso e demorado. Ao optimizar este protocolo em mosca-da-fruta estaríamos a 
ultrapassar essas dificuldades. No entanto, não foi possível terminar a experiência sendo por isso 
necessária a continuação deste projecto. Pudemos apenas concluir que a co-microinjeção de guideRNA 
com proteína Cas9 não é eficiente, uma vez que a concentração necessária de proteína Cas9 é muito 
maior do que a que foi possível utilizar neste projeto.  
 Por último, o protocolo foi utilizado em murganhos e neste caso, obtivemos 41 animais 
provenientes de microinjeção de guideRNA e proteína Cas9, mas nenhum apresentava fenótipo 
facilmente observável ao nível da pigmentação da pelagem. No entanto, estudos em tyrosinase em 
murganhos mostram resultados de animais sem fenótipo de pigmentação mas que apresentavam 
mutações quando genotipados, passo essencial para uma conclusão definitiva quanto à aplicabilidade 
deste método na geração de mutantes em murganho, mas que, infelizmente e por constrangimentos 
temporais não conseguimos efetuar em tempo útil.  
 Concluimos que conseguimos reproduzir com sucesso o protocolo em peixe-zebra. Em mosca-
da-fruta, o mesmo protocolo de produção e injeção de guideRNA poderá funcionar mas será preciso 
adpatar a entrega da proteína Cas9. Por útlimo, em murganhos parece que o protocolo a usar poderá 
ser muito semelhante ao do peixe-zebra, no entanto fica por confirmar o sucesso na produção de 
mutantes. 
 
 
Palavras-Chave: CRISPR, mutação, Knockout, mosaico, fenótipo 
  
4 
 
Abstract 
 
 Model organisms are non-human species, that due to similarities with the human organism, are 
studied in the expectation of discovering gene functions, cure for diseases, improvements in healthcare 
and welfare.  Danio rerio, Drosophila melanogaster and Mus musculus are examples of model 
organisms widely used in all biomedical research fields. To study gene function, production of 
knockout animals is an important approach. The CRISPR/Cas9 targeted mutagenesis technology offers 
the possibility of targeting any gene of interest as long as there is a proto-spacer adjacent motif (PAM) 
in that region, a gRNA and a Cas9 protein. Cas9 protein makes a DSB in the DNA that the cell tries to 
fix through the NHEJ mechanism. This mechanism is not always efficient and small base deletions or 
insertions may arise, causing a frameshift that leads to the production of a deficient protein or null 
protein, causing a knockout of the gene. A common protocol for gRNA production and knockout 
generation that fits all three model organisms above referred, is not yet available. In this project, we 
first did a proof of principle with a pre-existing protocol for gRNA production and knockout zebrafish 
production. When establishing the zebrafish protocol, the main objective was to use the same protocol 
structure to produce knockout animals in both fruit fly and mouse, making the necessary optimizations 
regarding differences in embryonic development. To do this, genes that would cause a phenotypic 
readout were chosen: tyrosinase in zebrafish and mouse, and yellow in fruit fly. The tyrosinase gene in 
zebrafish was successfully mutated and mosaic phenotypic and genotypic disruption was observed. 
Co-microinjection of gRNA for the yellow gene in fruit fly with Cas9 protein didn’t produce a positive 
result, since Cas9 protein is required in a much higher concentration in the cell. For this animal model, 
we concluded it was best to micro-inject the gRNA in embryos already producing the Cas9 protein. In 
mouse, injection of Cas9 protein and gRNA targeting the tyrosinase gene resulted in the successful 
generation of 41 animals, but we fail to observe a clear tyrosinase mutant.  
 
 
Keywords: CRISPR, mutation, Knockout, mosaic, phenotype 
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1. Introduction 
 
1.1 Model organisms and their manipulation to produce knockouts  
 
 Naturalist Charles Darwin (1809-1882) was on a voyage around the world on board of 
“Beagle” for 5 years. His observations and studies of specimens during those 5 years, led him to 
present his evolutionary theory and in 1859, he published “On the Origin of Species by Means of 
Natural Selection, or the Preservation of Favoured Races in the Struggle for Life”. Charles Darwin’s 
evolutionary theory (Darwin, 1869) says that all living beings have a common ancestor. Based on that 
theory, all organisms share a common ancestor and biology. This argument follows naturally to the 
conclusion that non-human organisms can be studied to pursue the ultimate goal of medicine 
development. Using animals in such studies instead of humans brings obvious advantages both at the 
experimental and ethical planes. Experiments in non-human organisms can bring benefits not just to 
humans, but also to the animals themselves. Work of Mendel in pea plants and Morgan in fruit flies, 
that identified Mendel’s determinants as the chromosomes, are a clear example. Model organisms are 
all non-human species that are biologically studied in the expectation of discovering gene functions, 
cure for diseases, improvements in healthcare and welfare that can then be applied in other organisms. 
Models are chosen according to the experimental manipulation that is planned.  Characteristics such as 
life cycle, genetic manipulation tools, housing requirements (cage, vials, type of feed, etc.…) and 
genetic similarity are important when choosing a model organism. According to Nature Glossary the 
definition for model organism is “An organism suitable for studying a specific trait, disease, or 
phenomenon, due to its short generation time, characterized genome, or similarity to humans; 
examples are a fly, fish, rodent or pig, whose biology is well known and accessible for laboratory 
studies” (Nature Education, 2017). 
 
Drosophila melanogaster as model organism and transgenesis techniques used 
 
 Drosophila melanogaster was probably the first animal being used for genetic studies by 
Thomas Morgan, who received the Nobel Prize in 1933 of Physiology or Medicine for discovering the 
role of chromosomes in heredity (Nobel Prize in Physiology or Medicine, 1933). Drosophila is a 
model organism widely used by researchers for several reasons: flies are easy and inexpensive to 
maintain in laboratory; there are almost non-ethical issues in using Drosophila, allowing almost any 
genetic modification; females can lay about 100 eggs per day (Shapiro, 1932); at 25 ºC it takes 10 days 
to have adult flies so many flies can be generated very fast; it has only 4 pairs of chromosomes, being 
the 4th so small that is usually discarded; females show meiotic recombination but males don’t 
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(Morgan, 1912); balancer chromosomes (modified chromosomes used to prevent crossing over 
between homologous chromosomes during meiosis) exist carrying genetic markers that are easily 
visible. These chromosomes allow for an homozygous lethal mutation to be maintained heterozygous 
in the population (Bloomington Drosophila Stock Center, 2013); and the full genome is already 
sequenced and fully annotated. The National Human Genome Research Institute made a comparison 
between the fruit fly and human genomes estimating that 60% of genes are conserved in both species 
and about 75% of human disease genes have a recognizable match in the fruit fly genome.  
 Transgenesis in the fruit fly was detected in 1982 through the works of Rubin and Spradling 
with transposable elements, a technique now called P-element Transgenesis, that is based on a 
transposon called P element, a highly mobile element present in the DNA (Rubin & Spradling, 1982). 
P-elements encode a functional transposase that enables them to “jump” inside a genome (Hummel, 
2008). For production of transgenic flies according to this technique, two constructs need to be 
microinjected into the embryo, one that contains the gene of interest and a marker gene (mini-white) 
and another one, called Helper plasmid, that contains the transposase that will catalyse the “jump” of 
the DNA of interest into the fly genome (Fig.1). Mini-white rescues the red colour of the fly eye, since 
microinjected flies have a white background. In P-element Transgenesis, the transgene is randomly 
incorporated in the fly genome making it a useful tool to produce transgenic animals, because the 
transgene of interest is expressed either way. It is possible to produce mutants using P element 
Transgenesis since an incomplete excision can occur. Fly embryos are microinjected in the syncytial 
stage, when the embryo is a multinucleated cell with no cytoplasmic membranes involving the nuclei. 
Microinjection in this stage increases the possibility of targeting every nucleus. Also, microinjection is 
made in the posterior end of the embryo where the pole cells will appear (pole cells give origin of the 
germline cells), increasing the chances of germ line transgene incorporation and subsequent 
transmission to progeny. 
 In P-element Transgenesis, integration of DNA is random but transgenesis in fly evolved and 
new techniques arise where DNA is integrated in known sites of the fly genome. One of those 
techniques is based on Integrase φC31, where an integrase isolated from a phage induces 
recombination between two non-identical sequences, one called attP (from phage) and the other called 
attB (from bacteria). This mechanism was translated into the production of transgenic flies, 
microinjecting a plasmid that contains an attB region into the fly embryo that already possesses an attP 
site similar to the attP site of the phage (Fig 2). The microinjected plasmid also contains a mini-white 
as marker gene (Groth et al., 2004). Integrase φC31 can be used in another approach using stocks 
originated from integration of a specific cassette randomly into the genome, that cassette stands for 
Minos Mediated Integration Cassette (MiMIC). MiMIC makes use of the transposon Minos, 
containing a DNA cassette flanked by 2 inverted attP regions. Replacement of this DNA cassette by a 
functionally relevant DNA element (enhancer, gene trap, etc) is achieved by φC31-mediated 
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Figure 1 – Drosophila Random P Transgenesis (Abdul Razzaq, n.d.) 
integration. In this case, original flies have yellow background and the cassette has a yellow+ marker, 
so the flies are phenotypically wildtype, but when microinjection is successful and the cassette is 
replaced, flies loose the yellow+ marker and become yellow (Venken et al., 2011). The latter 2 
techniques are not random like P-element Transgenesis but attP/MiMiC regions are in known regions 
of the genome and are useful to produce transgenic animals, not to study gene function (unless the 
gene of interest has an attP/MiMiC region and in that case, some strategies can be employed to 
produce a knockout, like the Gal4-UAS: system) (Ou & Lei, 2013).  
Mus musculus as model organism and transgenesis techniques used 
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 Mice were first used by Mendel in 1860 but he was forbidden to breed mice within the 
monastery so he started his work in sweet peas (The Jackson Laboratory). Lucien Cuénot, in 1902, 
was then the first person to use mice and he demonstrated the Mendelian inheritance in mammals, 
using the coat colours in mice (Cuenot, 1905). Mice are biologically very similar to humans and suffer 
from the same diseases for the same genetic reasons making them one of the most used model 
organism. On average, 85% of mouse coding regions are identical to human. Some genes are 99% 
similar but others are just 60% (National Human Genome Research Institute). Besides genetic 
similarity, there are other reasons that make mouse a good model organism, such as: one year in the 
mouse equals to 30 human years (Dutta & Sengupta, 2016), this accelerated lifespan allows the study 
of an entire life cycle; their maintenance is cost-effective, they are small to handle, reproduce fast; and 
can be genetically manipulated to mimic any human disease or condition. 
 Jon Gordon, in 1980, was able to produce the first transgenic mouse by microinjecting purified 
DNA directly into the pronuclei of fertilized mouse oocytes (Gordon et al., 1980).  This became a 
widely used technique for mouse transgenic production. But the integration of this DNA seems to be 
random (Lacy et al., 1983) making it impossible to replace, for example, a gene that causes a certain 
disease. Other technique used for transgenic and mutant mice production consists in the manipulation 
of mouse embryonic stem cells (ES cells). Using this approach it is possible to manipulate a desired 
locus by introducing a loss or gain of function in vitro (Bradley et al., 1984; Thomas & Capecchi, 
1987). ES cells are present in 3.5 day blastocysts and are pluripotent, meaning that are able to 
contribute to different cell lineages (Martin, 1981). When in a petri dish, these ES cells may be 
transfected with the desired DNA that is introduced into the cell’s genome by homologous 
recombination between the donor DNA and the target genomic locus of ES cell’s DNA.  Transformed 
ES cells that contain the desired alteration are then injected into blastocysts that are in turn transferred 
to a surrogate mother. Typically, surrogate mothers and ES cell donor animals have different colour 
coats. This way, the born pups that will have incorporated the altered ES cells will display a quimeric 
colour coat (Bradley et al., 1984; Koller & Smithies, 1992). The ES cells technique made it possible to 
knockout a gene through the homologous recombination mechanism but it is still a long and expensive 
process (Hall et al., 2009).   
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Figure 3 – Zebrafish Tol2 transgenesis system (Kawakami, 2007)  
Danio rerio as model organism and transgenesis techniques used 
 
 In 1981, George Streisinger was 
the first to clone a vertebrate and it was 
the zebrafish Danio rerio. George was the 
father of zebrafish as a research model 
and has turned it into a very useful 
scientific model organism to study 
development and gene function 
(Streisinger et al., 1981).  There’s an 
online resource, the Zebrafish Information 
Network (ZFIN) where genetic, genomic 
and developmental information can be 
found.  The reasons why zebrafish is such 
a good model organism are: its genome is 
already sequenced; has a rapid embryonic 
development attaining sexual maturity in 
60-90 days; adults are small and are 
housed in large groups, requiring few 
space and lowering the maintenance 
costs; adult zebrafish breed very fast and 
can produce until 300 embryos at a time; 
fertilization in zebrafish is external, allowing the easy manipulation; embryos also have the advantage 
of being large and transparent (Burke, 2016). Zebrafish has similar behaviour as compared to 
mammalian models concerning toxicity testing and diurnal sleep cycle (Jones, 2007).  Even existing 
70% of gene similarity between human and zebrafish (Howe et al., 2013), limitations in using 
zebrafish as an organism model exists, for example as a human disease model. Some human diseases 
are caused by genes that do not exist in zebrafish, making impossible to use this organism as a human 
disease model for a variety of human diseases. Zebrafish is also not a good organism model for human 
diseases that take place in a body part that zebrafish don’t have, like mammary glands or prostate 
(Burke, 2016).  
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Figure 4 – Zebrafish Morpholinos (Codarin et al., 2009) 
 
 
 
 
 
 
 
 
 
 
 
 
 Stuart and colleagues, in 1988, after publication of the first transgenic mice production 
(Gordon et al., 1980), applied successfully the same technique in zebrafish, with their group being the 
first to produce a transgenic zebrafish (Stuart et al., 1988). However, those results had a very low 
efficiency rate , and although this was being increased over time, a new technique using transposons 
has been developed in zebrafish, called the Tol2 transposon system (Kawakami & Shima, 1999; 
Kawakami et al., 2000). Evidence of this active transposon was first reported in Medaka fish in 1996 
(Koga et al., 1996). A couple of years later, Tol2 was isolated from a mutational insertion in the 
Medaka tyrosinase locus and showed to have autonomous mobility (Kawakami et al., 1998). The Tol2 
system consists on a construct containing 2 cis-regulatory sequences (CREs) from the Tol2 element 
positioned 5´and 3´ of a promoter sequence followed by a fluorescent protein. This construct was 
named Tol2 vector. The Tol2 vector is co-injected with mRNA encoding for the Tol2 transposase into 
a one-cell stage embryo. Once translated, the Tol2 protein will catalyse the excision of the region of 
the Tol2 vector between the CREs and its integration in the genomic DNA (Fig. 3) (Kawakami & 
Shima, 1999; K Kawakami et al., 2000; Kawakami, 2007). There’s another approach capable of 
blocking a gene in initial stages of embryo development, allowing the study of its function, the 
morpholinos (Nasevicius & Ekker, 2000; Summerton, 1999). Morpholinos are synthetic molecules and 
exist in two types: the ATG morpholinos, that block the initiation of translation of proteins, and the 
Splice morpholinos that bind and interfere with the RNA splicing machinery resulting on a truncated 
protein (Fig. 4). However, this mechanism is transient because morpholinos are degraded through time 
(Bill et al., 2009; Morcos, 2007). 
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 Neither the Tol2 system nor the Morpholinos are able to induce targeted mutagenesis in 
zebrafish and, in 2008, zinc finger nucleases (ZNFs) were adapted to create targeted double strand 
breaks in the zebrafish genome (Doyon et al., 2008; Meng et al., 2008). ZNFs were produced to cleave 
DNA (Kim et al., 1996) and are a fusion between a restriction enzyme, FokI, and a DNA recognition 
domain containing 3 (or more) zinc finger motifs. ZNF heterodimerization in a position of the DNA 
leads to a double-strand break (DSB). 
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Figure 5 – DSB repair: flexibility of enzyme functions lead to different repairs in a DSB 
break (Lieber, 2010). 
DNA double strand break repairs  
 
Cells fix double strand breaks in the DNA by two different mechanisms, homologous 
recombination (HR) or Non-Homologous End Joining (NHEJ).  Homologous recombination only 
occurs if a donor sequence with homology arms is present (Filippo et al., 2008), a technique used to 
produce transgenic animals. Otherwise, NHEJ will occur and for that mechanism a nuclease to 
reconstruct the damaged DNA, a polymerase to fill in the gaps and a ligase to restore the strand 
integrity are required (Ma et al., 2004). It seems obvious to think that these enzymes work by this 
order to reconstruct the DNA cut but these enzymes have a functional flexibility big enough to allow 
the NHEJ mechanism to occur in many ways (Fig. 5).  
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This flexibility can result in loss of nucleotides or junctions with nucleotide addition (Lieber, 
2007, 2010), causing a frameshift that can result on a different protein translation or the complete gene 
knockout (Puchta et al., 2015).  
 An animal that has a gene knockout is an organism in which a particular gene or genes have 
been made inoperative. And knocking out genes is important for research purposes. If we remove a 
piece from a machine it’s possible to know how it works and what’s the importance of that piece and 
its function, for genes is the same logic, by knockin out a gene it’s possible to understand what is its 
function. Nowadays, despite several animal genomes being sequenced, many genes still have an 
unknown function, and by knocking out a gene it is possible to study its function. Knockins (insertion 
of a gene) and knockouts are also widely used to produce and create disease models (Hall et al., 2009).
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Figure 6 - Direct repeated sequences of iap gene of E. coli. There are 29 highly conserved nucleotides, 14 of which 
(underlined in the bottom) contain a dyad symmetry. In brackets are the nucleotide numbers in the gene (Ishino et al., 
1987).   
1.2 Bacteria CRISPR adaptive immunity system  
 
 Viruses are the biggest predators of bacteria, infecting prokaryotic cells with its DNA or RNA 
and making the bacteria machinery transcribe and translate its genetic material. Bacteria have both an 
innate immune system, that recognizes certain infection characteristics, and an adaptive immune 
system that can recognize specific pathogen characteristics (Rath et al., 2015).  In 1987, in 
Escherichia coli, five homologous sequences of 29 nucleotides arranged in direct repeats with 32 
nucleotides interspacing were found (Fig. 6). Those sequences were called REP (from repeats) 
sequences and were thought to act as mRNA stabilizers (Ishino et al, 1987).  
 Later in 2000, Mojica’s group identified that those short-repeated elements, generally in 
clusters, had one peculiarity: sequences were always regularly spaced by a unique sequence of 
constant length (Mojica et al., 2000). They called those clusters SRSRs (Short Regularly Spaced 
Repeats). Another feature present in those clusters is the presence of a conserved sequence, called 
leader, that is located upstream of every cluster locus. This leader directs transcription (Rath et al., 
2015). Searching these SRSRs in all available microbial genomes,  resulted in hits in 20 microbial 
species widespread among physiological and phylogenetic groups (Mojica et al., 2000). In 2002, those 
sequences were named CRISPR (Clustered Regularly Interspaced Palindromic Repeats) (Jansen et al., 
2002), name that is used nowadays to refer to this molecular system. Alongside with CRISPR, three 
Cas (CRISPR-associated) genes were also identified. Cas genes are present in prokaryotes that contain 
CRISPR, absent in non-CRISPR-containing prokaryotes and are found to be located invariably 
adjacent to the CRISPR locus, suggesting that Cas genes and CRISPR have a functional relationship. 
Cas genes showed characteristic motifs of helicases and exonucleases (Jansen et al., 2002). 
 In 2005, work in S. pyogenes showed that CRISPRs could acquire phage DNA by discovering 
that seven out of the nine spacers included in S. pyogenes CRISPRs corresponded to a phage sequence 
(Pourcel et al., 2005). Another work, in this case in S. thermophilus, showed that about 75% of 
CRISPR spacers from this bacterium corresponded to S. thermophilus phages and 20% corresponded 
to S. thermophilus and Lactococcus lactis plasmids (Bolotin et al., 2005). Both these works pointed 
that CRISPR spacers have phage DNA and extra chromosomal origin, but it was Mojica’s group that 
proposed a role for CRISPRs in microbial immunity showing that those extra chromosomal elements, 
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Figure 7 – Bacteria CRISPR/Cas immunity system (Doudna lab http://rna.berkeley.edu/crispr.html) 
included in the spacers, fail to infect the cells (Mojica et al., 2005). In 2007 this hypothesis was further 
reinforced by experimental work in S. thermophilus by Barrangou and colleagues. They showed that 
resistance against a bacteriophage could be acquired by integrating a genome fragment of that phage 
into the CRISPR locus (Barrangou et al., 2007). Each spacer integration promotes a duplication of a 
new repeat, creating a new spacer-repeat unit. S. thermophilus also allowed the discovery of plasmid 
cleavage in this system. Cleavage of DNA was performed 3 nucleotides upstream of a proto-spacer 
adjacent motif (PAM) by an endonuclease. When an invading DNA appears, selection of which spacer 
precursors (proto-spacers) will integrate the CRISPR locus, is determined by the recognition of PAM. 
PAMs are usually 3 nucleotides long and differ between CRISPR types (Barrangou et al., 2007; 
Deveau et al., 2008; Horvath et al., 2008). In 2008, Brouns and colleagues demonstrated how those 
acquired spacers are used. CRISPRs are transcribed and a complex of Cas proteins cleaves the 
CRISPR RNA (crRNA) in each repeat, and retains the cleavage product that corresponds to a certain 
phage (Fig. 7). CrRNAs serve as guide RNAs that allow the Cas protein complex to interfere with the   
(Brouns et al., 2008). 
 Three types of CRISPR systems were identified, but type II is the system currently used to 
manipulate eukaryotic cells. In Type II CRISPR system, phage or plasmid DNA that tries to infect a 
cell is cut into small fragments halting the infection. In addition, those small fragments are 
incorporated into the CRISPR locus in short repeats (about 20 bp each). When new infection occurs, 
those loci are transcribed and those transcripts are processed into small RNAs (called CRISPR RNA – 
crRNA) that will guide Cas proteins to the target invading DNA based on sequence complementarity 
of crRNA and invading DNA (Fig. 8). In this system, only one protein, Cas9, is required to inactivate 
a gene (Jinek et al., 2012).  The Cas9 protein, discovered in Streptococcus species, has a key role in 
Type II CRISPR system, participating in processing crRNA and destroying target DNA. Cas9 contains 
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Figure 8 – CRISPR/Cas9 mechanism after 1st phage infection and 2nd infection by the same phage (Charpentier & 
Barrangou, 2017). 
two nuclease domains, a RuvC-like nuclease domain and a HNH-like nuclease domain, that cut the 
upstream strand and the downstream strand, respectively (Sapranauskas et al., 2011).  
 
 
 
 
 
 
 
 
 
 The CRISPR immunity system is divided into three stages: adaptation/acquisition, 
biogenesis/expression and interference. In the adaptation stage, a unique sequence from invading 
DNA, the protospacer, is incorporated into the CRISPR locus becoming a new spacer. This stage gives 
bacteria a genetic memory of invading DNA. Cas1 and Cas2 are two nucleases that are the key factors 
for the spacer integration into the CRISPR locus, but the mechanism through which these nucleases 
effect that integration is not fully understood. In Type II CRISPR, Cas9 is essential to identify the 
sequence that will be the protospacer by recognizing PAM sequences, and it is assumed that after that 
recognition, Cas9 recruits Cas1 and Cas2 to deliver the new protospacer into the CRISPR locus (Hille 
& Charpentier, 2016; Rath et al., 2015). The second stage, expression/biogenesis, refers to the 
transcription of the CRISPR locus to produce a CRISPR ribonucleoprotein complex. Primarily, the 
CRISPR locus is transcribed into pre-crRNA that is later processed into guide crRNAs, each 
containing memorized sequences of previous invaders. In type II system, it is known that a separate 
trans-activating RNA (tracrRNA) is required for the maturation of crRNA, but its mechanism is still 
unknown (Hille & Charpentier, 2016).  In the third and final stage, interference, crRNAs binds to Cas9 
protein and the complex locates the corresponding targets to be degraded. For interference to occur, 
the presence of PAM and complementarity between crRNA and invader DNA are necessary (Hille & 
Charpentier, 2016; Rath et al., 2015). 
 To target mutagenesis in vitro, Cas9 is complexed with crRNA and tracrRNA (Deltcheva et 
al., 2011). Both Cas9 nuclease domains cut the target DNA, with double strand breaks, 3 nucleotides 
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Figure 9 – Stages in CRISPR/Cas immunity system: adaptation, biogenesis and 
interference (Marraffini Laboratory - 
http://marraffini.rockefeller.edu/research.html) 
upstream of the PAM sequence, which in the case of Cas9 protein is NGG. Doudna and Charpentier 
showed that Cas9 protein required a base-paired structure between crRNA and tracrRNA to cleave 
DNA, so they developed a simpler system which combined crRNA and tracrRNA into a single guide 
RNA (sgRNA). Cas9 is effective with separate tracrRNA and crRNA as it is with sgRNA (Jinek et al., 
2012).  
 
 
 
 
 
 
 
 
 
 
 
 To produce mutant animals using the CRISPR/Cas9 technology, only microinjection of Cas9 
(in protein or in mRNA) and a sgRNA complementary to the chosen gene target is required. This 
technology offers many advantages over all techniques referred above: it is easier and cheaper to 
design and produce, since only Cas9 protein (or Cas9 mRNA) and sgRNA are necessary; sgRNA and 
Cas9 protein (or mRNA) can be directly injected into embryos; it is possible to make more than one 
mutation at once by co-injecting 2 or more gRNAs; the possibilities to target the mutation are bigger 
than ever since you can almost target any gene as long as a PAM sequence exists; it is also possible to 
make knock-ins with this technique by co-injecting oligonucleotides that will be incorporated into the 
genome by homologous recombination. However, limitations also exist: one of the major limitations 
of the CRISPR/Cas9 technology is off-targets: the mutation can occur in a non-specific region with 
similar homology to the real target site (even tough, off targets of CRISPR technology are fewer than 
other techniques); even with microinjection in 1-cell stage embryos, it does not mean that the mutation 
will occur in all cells nor that it happens in both alleles, creating mosaic animals; and the generations 
of multiple different mutated alleles. When DSB happens, the repair process of NEHJ is different in 
every animal producing different mutations from the same cut (The Jackson Laboratory b). 
CRISPR/Cas9 has been successful in many animals, invertebrates and vertebrates. Indels have been 
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Figure 10 – Different body color between a Drosophila 
wildtype female (1) and a Drosophila yellow female (2)  
(Rampasso & Vilela, 2017) 
introduced at about 90% efficiency in C. elegans, Drosophila, rabbit, chicken, mouse, zebrafish and 
human cells (Bortesi et al., 2016). 
1.3 The tyrosinase and the yellow gene  
 
 Tyrosinase is an enzyme responsible for the conversion of tyrosine into melanin in 
melanocytes. Melanin gives colour to skin, hair and eyes and is also found in the retina were has it a 
role in vision (Genetics Home Reference - U.S. National Library of Medicine, 2017). Mutations in the 
tyrosinase gene cause oculocutaneos (OCA1) in humans and identical phenotypes are found in mice 
(King et al., 2003). In mice, a single nucleotide exchange in the coding region of tyrosinase causes the 
classical albino mutation (Jackson & Bennett, 1990). In zebrafish, the tyrosinase gene is expressed 
first in the retinal pigment epithelium and then in the neural crest (Camp & Lardelli, 2001). The 
tyrosinase gene was chosen in this project exactly because it is expected that after knocking out the 
tyrosinase gene a lack of pigmentation phenotype would be easily observed.  
 
 The yellow gene (y) is located in the 
drosophila X chromosome and controls the 
pigmentation pattern of the adult fly cuticle and 
larval mouth parts. When the yellow gene is mutated 
adult flies have a phenotypically distinct yellow 
pigmentation on its cuticle (Biessmann & Alberts, 
1985). Just as for the tyrosinase gene, the yellow 
gene was chosen for convenient phenotype scoring: 
yellow knockout mutants will have yellow cuticles 
and can be easily differentiated from wildtype flies 
with normal brownish cuticle (Fig. 10). 
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2. Aims 
 
 Despite the fact that the CRISPR/Cas9 technique is already well established in these three 
organisms, there is a lack of a general common protocol suitable for all 3 animals. In this project, our 
focus was to establish a single protocol for guide RNA production and CRISPR mediated knockout 
generation that would fit all 3 model organisms: Danio rerio, Drosophila melanogaster and Mus 
musculus. 
The main objective of this MSc project was to optimize a general protocol of guideRNA 
production that would fit three model organisms, Danio rerio, Drosophila melanogaster and Mus 
musculus, commonly used at CF and produce mutant animals using CRISPR technology. To achieve 
this goal, we: 
• Chose a gene that would be responsible for an observable phenotypic characteristic. 
The knockout of that gene was expected to generate a different phenotype;   
• Used a guideRNA production protocol that had been already shown to be successful 
in Danio rerio; 
• Started with the validation of such a protocol in Danio rerio using embryo 
microinjection of guideRNA and Cas9 protein; 
• Moved to Drosophila melanogaster and adjusted microinjection concentrations of 
guideRNA and Cas9 protein to produce mutant individuals; 
• Performed embryo microinjection in Mus musculus also adjusting the microinjection 
concentrations to produce mutant individuals.  
A second objective of this project, after producing mutant animals, was to establish a mutant 
stable line. To achieve this goal, we: 
• Crossed Danio rerio mutants between themselves and screened the progeny for non-
pigmented individuals  
• To establish a line tyrosinase knockout, injected animals need to be crossed with 
wildtype individuals 
• Crossed Drosophila melanogaster mutants with yellow flies for two generations and 
screened the progeny for yellow cuticle colour to establish a mutant stock for yellow 
knockout; 
• Crossed Mus musculus mutants with albino animals and screened the progeny for non-
pigmented animals, then crossed between themselves to establish a stock for 
tyrosinase knockout.  
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Due to the organism diversity, every step after the production of the guideRNA is different so, 
the next chapters, Material and Methods and Results, will be divided by organism.  
3. Material and Methods 
 
3.1 Production of guideRNA  
 
To produce guideRNA, a modified protocol from Gagnon et al (2014) was used (Gagnon et 
al., 2014).  
Template for guideRNA production 
 
To produce guideRNA, a first template is generated, consisting on two oligos annealed. The 
first is a variable gene-specific oligo, comprising a suitable promoter, the target site (without the PAM 
region) and an overlap region. This overlap region will anneal with the second oligo that is constant 
and contains tracrRNA that will bind to the Cas9 protein.  
A suitable promoter can be T7 or SP6. If the guideRNA sequence starts with GG, a suitable 
promoter is T7, if it starts with GA then is SP6. If there is no GG or GA, a GGG upstream to the 
guideRNA and the T7 promoter are added.  The sequence for the T7 promoter is 
TAATACGACTCACTATA and for the SP6 promoter is ATTTAGGTGACACTATA. The overlap 
region is GTTTTAGAGCTAGAAATAGCAAG. In the end, there are two template possibilities: 
T7: TAATACGACTCACTATA -N20-GTTTTAGAGCTAGAAATAGCAAG  
SP6: ATTTAGGTGACACTATA-N20-GTTTTAGAGCTAGAAATAGCAAG 
where N20 is the target site sequence chosen to the target gene.  
The constant oligonucleotide, regardless of the choice of the promoter or target gene, is:  
5’AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTT
AACTTGCTATTTCTAGCTCTAAAAC 3’ 
These oligonucleotides were synthesized by Sigma. 
The first step of the guideRNA production protocol was the annealing of both 
oligonucleotides:  
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Table 3 – Fill in with T4 polymerase 
Table 2 – Thermocycler conditions for annealing 
oligonucleotides 
Table 1 – Solution for annealing of oligonucleotides 
Reagent  μl
dNTPs (10nM) 2.5
10x NEB buffer 2.2
100x NEB BSA 0.2
T4 NEB DNA Polymerase 0.5
Water 4.8
 10 μl total
95ºC 5 minutes
95ºC ramp. Rate to 85ºC -´2ºC/second
85ºC ramp. Rate to 25ºC -´0.1ºC/second
4ºC Hold
Oligonucleotide  μl 
Gene-specific (100 μM) 1 
Constant (100 μM) 1 
Water 8 
   10 μl total 
 
Followed by a temperature cycle using a thermocycler: 
 
 
  
  
  
The next step was the Fill in with T4 polymerase (NEB) to produce a double strand 
oligonucleotide:  
 
 
 
 
 
Samples were incubated for 20 minutes at 12ºC.  After incubation 80 μl of water was added to 
the template followed by purification using a PCR cleanup column, eluting in 30 μl of water. Expected 
DNA yield should be between 100-200 ng/µl. After measuring the DNA, a 1% agarose gel or QIAxcel 
ScreenGel®, was performed to verify that the product had the correct size of ~120bp. 
 
Transcription of template to produce guideRNA 
 
After purification, the template was in vitro transcribed with Ambion Megashortscript T7 or 
Megascript SP6 kit, depending on the promoter, to produce guideRNA. From this point onward all 
procedures were made in RNase-free conditions.  To maximize the transcription, the incubation step 
was prolonged to an overnight incubation when using T7 kit and 4 hours when using SP6 kit.  
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Extraction and Purification of guideRNA  
 
Recovery of guideRNA was performed with Qiagen micro-RNA purification Kit or with a 
Phenol/chloroform extraction: to 20 µl of transcription product, 115 µl of nuclease-free water and 15 
µl of Sodium Acetate Stop (Ambion kit) were added. Next, 150 µl of phenol/chloroform pH 4.5 (or 
pH 8) was added, mixed well and centrifuged for 5 minutes at 4ºC. Upper layer (lower layer if using 
phenol/chloroform pH 8) was transferred to another tube with 350 µl 100% EtOH, incubated for 15 
min at -80ºC or with dry ice to precipitate RNA. RNA was centrifuged 20 minutes at 4ºC to form a 
RNA pellet. The supernatant was discarded and the pellet washed with 500 µl 70% EtOH spinning 15 
minutes at 4ºC. The supernatant was discarded again and the pellet was left to dry and resuspended in 
20 µl of nuclease-free water. RNA was aliquoted according to the concentration needed for 
microinjection. 
 
3.2 Cas9 Protein  
 
Cas9 Protein was batch-produced at 1 mg/ml in 20mM Tris Ph 8, 10mM MgCl2 and 0.2M KCl 
buffer, at the Weizmann Institute of Science, Israel.  
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4. Danio rerio (zebrafish)  
 
4.1 Methods 
 
Targeting strategy  
 
For zebrafish, the tyrosinase gene was chosen for mutation. Tyrosinase is responsible for the 
black pigmentation of the body and eyes of the animal. So, a knockout of this gene should produce a 
visible phenotype with lack of pigmentation.  
 
Choosing guideRNA  
 
In zebrafish, the CRISPRz database was used to look for guides already validated for the 
zebrafish tyrosinase gene. We chose the one used by Jao et al. (2013): 
GGACTGGAGGACTTCTGGGGAGG (PAM site underlined). Since tyrosinase guideRNA (without 
the PAM site) started with GG, a suitable promoter was T7, thus being the tyrosinase gene-specific 
oligonucleotide (ordered from Sigma): 
TAATACGACTCACTATAGGACTGGAGGACTTCTGGGGTTTTAGAGCTAGAAATAGCAA
G 
The guideRNA production protocol was performed and guideRNA was ready for 
microinjection.  
 
Danio rerio breeding 
 
Zebrafish were housed at the CF Fish Facility. Wildtype TU adults (around 6 males and 12 
females) were crossed for each microinjection trial, setting 6 crosses for each trial (1 male to 2 
females). Those crosses were made between 4 and 6 p.m. with fish housed in spawning tanks. 
Spawning tanks contain an insert reservoir, that have holes in the bottom, and a spacer that fits the 
tank, separating males and females from physical contact, but sharing the water. Animals stay 
overnight in these tanks being close to each other but not being able to breed, so when the spacer is 
removed early in the morning (when the lights turn on), fish spawn and eggs are fertilized. Spacers are 
taken one at a time, meaning that each cross produced embryos for a single microinjection. When the 
first laying of the first cross was injected, then the spacer from the second cross was removed, and so 
on.  Eggs fall through the holes in the insert reservoir, preventing the cannibalization of the embryos 
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Figure 11 – Agarose plates and zebrafish embryo alignment. Image modified from 
Wang et al. and Lu Zhe (Wang et al., 2013; Zhe, n.d.) 
by the parents. Fish were used to breed once a week. Eggs were collected into petri dishes with the 
help of a tea strainer and blue water (Methylene blue) and were ready to be aligned for microinjection. 
After laying, animals were housed back into the housing tanks (Martins et al., 2016). All animal 
procedures were made under rigorous standards of animal welfare and complied with the 2010/63/EU 
(European Parliament and the Councli pf the European Union, 2010). 
 
Microinjection needles and microinjection set-up 
 
Agarose petri dishes with trenches (Fig. 11) were used to align and microinject embryos. 
Alignment and microinjection of embryos were performed under a Zeiss Discovery V8 scope and 
microinjection with a PV820 Pneumatic Picopump (WPI). Microinjection needles were bought from 
Biomedical Instruments and were loaded with Eppendorf Microloader™ tips.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Embryo Microinjection  
 
Collected embryos were aligned with the cell positioned to the right side so it can be directly 
injected (Fig. 11) Only one-cell stage embryos were microinjected, embryos in other stages were 
discarded. Uninjected embryos were also kept as controls for each laying/cross.  
Different concentrations of guideRNA and Cas9 protein were tested (Table 4). Phenol red was 
added to the mix to serve as a visible marker for the injection into the embryo. After injection, 
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Table 4 – Microinjection concentrations of gRNA and Cas9 
protein into zebrafish embryos  
Cas9 Protein (ng/µl) sgRNA (ng/µl)
210 526
260 174
260 438
315 526
500 438
600 200
embryos were incubated and bleached (to disinfect embryo surface) at 24hpf. Survival rates were 
recorded 24 hours after injection (See Appendix 1). 
 
 
 
 
 
 
 
 
 
Screening for mutations  
 
Forty-eight hours after injection it was possible to evaluate the result from targeting the 
tyrosinase gene because tyrosinase expression already started (Camp & Lardelli, 2001). Individuals 
with visible phenotypes were incubated until 5 days old, at which age larvae entered the nursery. For 
non-phenotype targeting there is a possibility to screen for the mutation in early stages by DNA 
extraction from 24hpf embryos, following HotSHOT protocol (Meeker et al., 2007).  
The HotSHOT protocol consists in collecting pools of two embryos into a PCR strip (without 
blue water; if not possible, blue water can be removed with a micropipette) with 50 μl of 50mM NaOH 
to cause cell lysis during a 15 minutes incubation at 95ºC, followed by a cooling step at 4ºC. If using a 
thermomixer for incubation, ice can be used to cool down the samples; if using a thermocycler, an 
additional step of 4ºC can be added. For buffering, 5 μl of 1mM Tris-HCL pH 7.5 was added to the 
samples. After embryo DNA extraction, a 25 μl PCR reaction mix was prepared using 5 μl of 
extracted embryo DNA (See Appendix 5 for primers used).  Uninjected embryos were always used as 
controls. After PCR reaction (Table 5), samples were loaded in a 3% agarose gel for 1 hour at 80V. 
Uninjected eggs should have a single band while injected positive eggs should have a smear or more 
than one single band. This method can and should be used to test guide efficiency, according to which 
a respective number of fish are raise to adulthood. The PCR product was purified and sent for 
sequencing. If the CRISPR process is successful and there is integration or deletion of nucleotides in 
the target region, this can be easily seen in the sequence chromatogram that will be a mix of different 
alleles present in the sample.   
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Initial Denaturation 95°C 30 seconds
95°C 30 seconds
60°C 30 seconds
68°C 2 minute
Final Extension 72°C 5 minutes
Hold 12ºC
Temperature
34 Cycles
Time
Primers 
 
For PCR from embryo DNA extraction, amplicons should be around 100bp, 50bp from the cut 
site to each side, the smaller the better to search for indels, but for the tyrosinase gene the primers used 
were the same as Joa et al. (2013) and amplicons were around 315bp (Appendix 5).   
 
Genotyping the adults  
 
By two months old, fish are big enough to be fin clipped to sample tissue for genotyping. 
DNA extraction was performed with proteinase K: Tissue was sampled into 200 μl of lysis Buffer (50 
Nm Tris-HCL pH 8.5, 1 mM EDTA and 0.5% Tween-20) and proteinase K was added to a final 
concentration of 200 μg/μl immediately before DNA extraction (samples can be frozen before 
extraction), samples were incubated for 2h at 55ºC in a thermomixer followed by a denaturation step 
of 10 minutes at 95ºC. After incubation, samples were centrifuged 10 minutes at 13.200rpm at 4ºC. 
The supernatant was collected to a new tube and stored at 4ºC for up to 3 months or -20ºC for longer 
periods.  
After DNA extraction, a 25 μl PCR reaction (Table 5) was performed and samples loaded on 
QIAxcel ScreenGel®. Different band sizes (or a smear – QIAxcel ScreenGel® has an “smear 
analysis” option”) should appear.  
Table 5 PCR cycle for tyrosinase gene 
 
 
 
 
 
 
Sequencing  
 
For sequencing the mutation, positive fish should be outcrossed and the F1 genotyped. The 
PCR product sent for sequencing and screened for jammed chromatogram near the PAM site. For the 
tyrosinase gene in particular, incrosses between F0 mutant individuals were made and non-pigmented 
progeny was grown to adulthood for genotyping.  
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Figure 12 – QIAxcel ScreenGel®, for tyrosinase gRNA 
template 
4.2 Results 
 
GuideRNA production 
 
After annealing the oligos and fill-in 
with T4 polymerase, the template was purified 
using a PCR column (QIAquick PCR 
Purification Kit) and eluted in 30 μl of water. 
DNA concentration was expected to be 100-
200ng/μl, tyrosinase template was 145 ng/μl. 
Template was then loaded in QIAxcel 
ScreenGel®, and a band of ~120bp was 
observed (smaller fragments are primer dimer) 
(Fig. 12) (as described in protocol). 
RNA extraction with Qiagen micro-
RNA purification kit showed that very few 
RNA was extracted, 54 ng/μl in our first 
attempt and 10 ng/μl in our second attempt, 
which was not sufficient to microinject. Based 
on these results, we did a comparison between 
RNA extraction with the Qiagen kit and 
Phenol/chloroform extraction. After in vitro 
transcription, the sample was divided into two 
tubes and we tested the 2 protocols. With 
phenol/chloroform we could extract 3278 ng/μl while with Qiagen kit we were only able to extract 
20,8 ng/μl. According to the ratios of the absorbance parameters and by applying the Beer-Lambert 
Law, guideRNA extracted with Phenol/chloroform was contaminated with protein (A260nm/A280nm = 
1.66) but free from organic contaminants (A260nm/A230nm = 2.26), so we therefore chose to follow the 
phenol/chloroform protocol for RNA extraction.   
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2 1 3 4 
Figure 13 – PCR amplification of 
314bp fragment of the tyrosinase 
zebrafish gene run in 1% Agarose gel: 
Amplification from fin sample genomic 
DNA preparation (1) Amplification 
from a 24hpi embryos genomic DNA 
preparations (2 and 3), geneRuler 
200bp (Thermo Scientific) (4). 
Screening for mutations 
 
DNA embryo extraction 
 
At 24hpi embryo DNA was extracted with 10 pools of 2 
injected embryos each and 2 pools of two non-injected embryos 
as control but nothing was amplified in the PCR reaction. A new 
pair of primers and different enzymes were tested but still 
nothing was amplified. Next, extraction from DNA embryos and 
fin samples were compared. Only by using DNA extracted from 
fin samples was it possible to amplify the correctly sized band 
(Fig. 13).  
In an effort to understand and troubleshoot lack of 
amplification of the tyrosinase fragment from 24hpi genomic 
DNA template, we tested different amplification protocols: 
Protocol 1 – protocol from HotSHOT using Thermocycler for incubation and 5 μl of template DNA 
for PCR reaction 
Protocol 2 – protocol from HotSHOT but using Thermomixer for incubation and an additional final 
step of 5 minutes centrifugation at 13550 rpm and 1,5 μl template DNA for PCR reaction  
Different genes regions were amplified, in the tyrosinase gene and DIA1R gene, as a control. 
The primers used for amplification of tyrosinase gene were the same ones that worked for the fin 
sample and that were used by Jao et al. (2013). For amplification of the DIA1R gene another pair of 
primers that had also worked for the fin sample, were used. Results from the above PCR reactions are 
in Figure 14. 
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Figure 14 - Left panel: QIAxcel ScreenGel® analysis (1) protocol 1 for tyrosinase gene; (2) protocol 1 for DIA1R gene; (3) 
protocol 2 for tyrosinase gene and (4) protocol 2 for DIA1R gene. On the right, there’s an overall result table with DNA 
concentration measured in the samples    
Figure 15 – PCR amplification of 314bp fragment of the tyrosinase 
zebrafish run in 1% Agarose gel: Amplification from 72h larvae genomic 
DNA preparation (1); Amplification from 5-day-old larvae genomic DNA 
preparation (2); GeneRuler 200bp (Thermo Scientific) (3)  
 
 
 
 
 
 
 
 
 
 
 
As we can see from figure 14, we suceeded in amplifyng DIA1R gene with template DNA 
extracted from 24h embryos but fail to amplify tyrosinase gene., in both embryo DNA extraction 
protocols. With these results and since extraction using the HotSHOT protocol clearly worked, we 
decided to extract genomic DNA from different ages and use genomic DNA extracted as DNA 
template for PCR reaction to see when was the tyrosinase gene amplified. For genomic DNA extracted 
from 72hpf larvae, no amplification was detected but with genomic DNA extracted from 5-day-old 
larvae a very faint band starts to appear (Fig. 15). 
  
1 
1 
3 
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Figure 16 – PCR amplification of 341bp fragment of the tyrosinase zebrafish 
run in 1% Agarose gel: GeneRuler 50 bp (Thermo Scientific) (1); 
Amplification from 24 h embryos genomic DNA preparation (in pools of two 
embryos) (2, 3, 4, 5, 6 and 7).  
Figure 17 – Injected 72h larvae for tyrosinase knockout: Lack of pigmentation in some cells of the 
eye (A) and wild type phenotype (B). 
 
In another approach, we tested the addition of DMSO to the PCR 
reaction mix of 24hpf and 72hpf embryo DNA extraction (Fig.16).  These 
results were not pursued since animals were already growing and for 
tyrosinase in specific (that causes a phenotypic result when mutated), DNA 
embryo extraction was not essential.   
 
 
 
Phenotype screening  
 
At 48hpf, injected embryos were screened for lack of pigmentation and the number of 
individuals with mosaicism was scored. Although in our first microinjection trial we did not see a lack 
of pigmentation in larvae, we still decided to grow some fish and some adult individuals did grow with 
non-pigmented cells. So, despite the fact that this mutation causes lack of pigmentation, it is possible 
that sometimes it could not have a larval phenotype. See Appendix 2 for mosaic individuals that were 
identified and respective microinjection mix concentrations. Eighteen larvae were identified with 
mosaicism, but in total we had 40 fish that showed pigmented mosaicism as adults (see Figure 17 for 
mosaicism example in larvae). This phenotype was achieved with different concentration mixes 
(Appendix 2). Mosaic animals that were raised but that didn’t show a lack of pigmentation as larvae, 
were obtained from our first injection with 260 ng/μl of Cas9 protein and 174 ng/μl of sgRNA.  
 
  
 
 
 
 
 
 
 
 
 
1 
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Graphic 1: Embryo survival rate: Control embryo survival rate vs injected embryo survival rate in different 
microinjection concentrations of Cas9 protein and guideRNA (A, B, C, D and E). A – 260 ng/μl Cas9 
protein + 174 ng/μl guideRNA, B – 260 ng/μl Cas9 protein + 438 ng/μl guideRNA, C – 500 ng/μl Cas9 
protein + 438 ng/μl guideRNA, D – 315 ng/μl Cas9 protein + 526 ng/μl guide RNA and E – 600 ng/μl Cas9 
protein + 200 ng/μl guideRNA 
 
Table 6 Mosaic animals with lack of pigmentation phenotype found 
according to concentrations mixes 
 
 
 
 
Embryo survival rates were different from uninjected embryos and injected embryos, being 
lower in the injected ones. Despite results from Condition A (see Graphic 1) that are probably due to 
the lack of experience, that was optimized trough trials, injected embryo survival is close to control 
embryo survival rate in all other conditions (B, C, D and E). Also, it seems that toxicity does not affect 
embryo survival, since that the lowest concentration mix condition (B) showed very similar survival 
rate to the most concentration mix conditions (D and E). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Genotyping  
 
Genotyping F0 injected animals  
 
Fourteen adult fish (F0 injected animals) were genotyped for screening indels. TU wildtype 
DNA was used as a control. All samples amplified the wildtype band, but also amplified smaller or 
bigger fragments that indicate indel occurrence (Fig. 18). Overall table of results of measured band 
sizes can be found in Appendix 3.  
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Figure 18 – Screening for indels: Wildtype sample (F04 TU) amplified DNA with ~315 bp, all 
other samples were from mosaic individuals that in addition to wildtype band, also showed 
smaller or bigger fragments proving that guideRNA cut the DNA and NEHJ events have occurred.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sequencing 
  
 PCR products from these samples were sent for sequencing, but it was a very jammed 
chromatogram making it impossible to draw any conclusion. To really get conclusions of which indels 
have really occurred it may be best to run a high concentration agarose gel and extract each amplicon 
and send it for sequencing, which was not done due to time constrains.  
 
Genotyping F1 fish 
 
Non-pigmented larvae (Fig. 19) from incrosses of mosaic animals, were grown and fins 
sampled at 2-month-old fish. From figure 19, it’s possible to see that all non-pigmented individuals 
(D01 – D08) lack the wildtype amplicon (D09), and instead, are composed of different F0 mutations. 
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Figure 19 – Genotyping of Non-pigmented incrossed animals (left side); Non-pigmented 
72h larvae (right side) 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
34 
 
5. Drosophila melanogaster (fruit fly)  
5.1. Methods  
Targeting strategy  
 
For fruit fly, yellow was the targeted gene to be knockout. Yellow is a spontaneous recessive 
mutation that gives a yellow colour to the body of the fly (Biessmann & Alberts, 1985). Yellow 
mutation already exists and it’s been part of fly crossings strategies. In this case we tried to mimic the 
existing spontaneous mutation of yellow body colour in wildtype flies and vasa_Cas9 flies.  Vas_cas9 
(Bl #51324) are flies that express Cas9 protein under the germ-line promotor vasa and were used for 
microinjection of only guideRNA instead of Cas9 protein and guideRNA co-injection in non-
expressing cas9 flies.  
Choosing guideRNA  
 
In Drosophila, guideRNA was found in BreakingCas site (Oliveros et al., 2016) using the 
yellow gene sequence (NM_143655.4) as template for search fit guides. The guide chosen had a 99.9 
score: GGTTTTGGACACTGGAACCGTGG (PAM site underlined). This guide was also used in 
Basset et al. (2013) experiments. Since yellow guideRNA (without the PAM site) started with GG the 
suitable promotor was T7, being the yellow gene-specific oligonucleotide (ordered from Sigma): 
TAATACGACTCACTATAGGGGGTTTTGGACACTGGAACCGGTTTTAGAGCTAGAAATA
GCAAG 
Production of guideRNA was performed according to the protocol described in “Production 
guideRNA” methods section, page 16 and it was ready to microinject.  
 
Microinjection needles and microinjection set-up 
 
Embryos were aligned under a Leica MZ6 scope and microinjected under a Zeiss Primovert 
microscope adapted to microinjection, with a Narishige micromanipulator connected to a PV820 
Pneumatic Picopump. Capillaries from WPI (Thin wall single- barrel Standard Borosilicate 1mm with 
filament) were pulled on a Sutter P-2000 needle puller to produce microinjection needles. Needles 
were loaded with Eppendorf Microloader™ tips. 
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Embryo Microinjection  
 
Flies (Canton S and Bl#51324) were maintained in laying pots with petri dishes containing 
apple juice and yeast. Embryos were collected between 40min-1h after dish change and injected as 
soon as possible while still in a syncytial stage. For microinjection, embryos were dechorionated first 
with 50% bleach and aligned (around 50 per slide) all to the same side. Embryos were covered with oil 
10s (VWR  chemicals) to prevent dehydration but still allow gas exchanges since embryos were 
dechorionated (Al-Dosary et al., 2010). Microinjection was performed in the posterior side of the 
embryo, where pole cells, which will later give rise to the fly gonads, are located, increasing the 
chances of the mutation to occur in the germ-line and being transmitted to the progeny. First, 
injections of Cas9 protein with guideRNA into Canton S (wildtype) flies were performed. Different 
concentrations of Cas9 protein, to a maximum concentration of 800 ng/ μl, were tested. Next, I 
performed a series of injections into vas_cas9 flies that already express the Cas9 Protein, of only 
guideRNA at 500 ng/ μl or 1000 ng/ μl. Twenty-four hours after injection, larvae were collected into a 
vial with food and yeast and were left 10 days at 25ºC until adult eclosion.  
Screening for mutation  
 
In flies injected with Cas9 protein and guideRNA, one should see body colour mosaicism in 
the F0 injected flies, as for the zebrafish tyrosinase injections. To obtain a whole-body yellow fly, the 
mosaic F0 males should be individually crossed to virgins from yellow stock. If the mosaicism of the 
F0 male extends to the germ-line, a subset of the F1 females should now be all yellow. For vas_Cas9 
flies, that only express Cas9 protein under a germ-line promotor, F0 generation should not have any 
phenotype for yellow. To follow the mutation in this case, injected males should be crossed with 
yellow virgins, and F1 progeny virgin females should be crossed with yellow males.  If the strategy is 
successful, a subset of F2 males will carry the yellow mutation and have a yellow body phenotype. In 
this case, F0 animals will only be mosaic in the germ-line that is the site of Cas9 production.  
 
5.2 Results 
GuideRNA production 
 
After annealing the oligos and fill-in with T4 polymerase, template was purified using a PCR 
column (QIAquick PCR Purification Kit) and eluted in 30 μl of water. Concentration of DNA was 
expected to be between 100-200ng/ μl, yellow template was 150 ng/ μl. Template was then loaded into 
a 1% agarose gel, a band of ~120bp was observed (Fig. 20) (as described in protocol). 
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Figure 20 – Annealed and filled-in templates on 1% 
agarose gel, for yellow (2) tyrosinase mouse guide 1 (3) 
and tyrosinase mouse guide 2 (4). GeneRuler 50 bp 
(Thermo Scientific) (1) 
 
RNA extracted with Phenol/chloroform was 1930 ng/ μl. According to the 
ratios of the absorbance parameters and by applying the Beer-Lambert Law, 
guideRNA was contaminated with protein (A260nm/A280nm = 1.51) but free from 
organic contaminants (A260nm/A230nm = 1.99). 
 
 
 
 
Screening for mutation 
   
When microinjecting Cas9 protein and guideRNA into drosophila embryos, it was expected 
that mosaic flies would appear, but no phenotype was present and all F0 injected flies had 
homogeneous wildtype colour cuticle. These results are consisting with Lee et al. (2014) findings 
where his group only achieved mutations, when injecting Cas9 protein, at a 4000 ng/ μl final 
concentration (Lee et al., 2014). Unfortunately, our Cas9 protein stock was at a 1000 ng/ μl and, 
bearing in mind that the guideRNA was co-injected further diluting our Cas9 protein solution, the 
maximum Cas9 protein concentration we could achieve for microinjection in this project was 800 
ng/μl. Microinjection concentrations can be found in Appendix 4. To further proceed with this 
strategy, we should next try to inject Cas9 coding plasmid instead of protein (Screening strategy in 
Diagram 1). 
There is yet another strategy possible in this model system that is the use of Drosophila stocks 
already expressing the Cas9 protein. In this case, only the guideRNA should be injected (see Diagram 
2). If the Cas9 is being expressed under the control of a germ-line promoter (eg. Vasa-Cas9), no 
mosaics will be seen in F0 injected flies. However, if the strategy is successful, some of the F1 
females, resulting from F0 injected males crossed to yellow virgins, will carry the induced yellow 
mutation and have a yellow phenotype. Unfortunately, we did not have available the correct Cas9 
stock to follow the second strategy. Instead, we had a Cas9 stocks with the Cas9 transgene positively 
marked with a yellow rescue gene (y+). In this case, the crossing scheme to recover possible 
successful yellow induced mutations further complicates and an extra generation is necessary (see 
Diagram 3). 
1 
2 3 4 
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Diagram 1 – GuideRNA and Cas9 protein/plasmid microinjection scheme for mutation screening 
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Diagram 2 -  Injection of guideRNA for yellow gene in vasa-Cas9 flies and screening for mutation 
 
 
 
If successful, some F0 flies will 
be mosaic for yellow but only 
in the germ-line 
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Diagram  3 – Injection of guideRNA for yellow gene in vasa-Cas9 y+ flies and screening for mutation 
 
 
 
 
 
 
 
 
 
 
 
 
F2 males: If 
successful, some F2 
males would be yellow 
If successful, some F0 flies will 
be mosaic for yellow but only 
in the germ-line 
Pick individual virgin 
females and cross them 
with yw males 
 y*/y ;; +/+ 
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6. Mus musculus (mouse)  
6.1 Methods  
 
Targeting strategy  
 
For mouse, the gene chosen to be knockout was, like Danio rerio, the tyrosinase gene. The 
tyrosinase gene has the same function as in Danio rerio, giving black pigmentation to the body of the 
mouse. So, a knockout of this gene should produce a visible phenotype by lacking colour in body and 
eyes. 
Choosing guideRNA  
 
In Mus musculus, guideRNA was also found in the BreakingCas site (Oliveros et al., 2016) 
using the tyrosinase gene (ENSMUSG00000004651) sequence as a template in the search for fit 
guides. In this case, there were two chosen guides. One near the first ATG: 
GGTCATCCACCCCTTTGAAGGG (PAM site underlined) with 86.7 score. And another one, that 
was the best-scored guide for this gene, with 98.8 score: GGACCACTATTACGTAATCCTGG (PAM 
site underlined). Since tyrosinase guideRNAs (without the PAM site) started with GG the suitable 
promoter was T7, being the tyrosinase gene-specific oligonucleotides (ordered from Sigma): 
Tyr_grna1: TAATACGACTCACTATAGGGGGTCATCCACCCCTTTGAAGGTTTTAGAGCTA
GAAATAGCAAG 
Tyr_grna2: TAATACGACTCACTATAGGGGGACCACTATTACGTAATCCGTTTTAGAGCTA
GAAATAGCAAG 
Production of guideRNA was performed according to the protocol described in “Production 
guideRNA” methods section, page 16 and it was ready to microinject.  
Mus musculus animals  
  
Animals were housed in the CF Vivarium. For this project, 25 C57Bl/6J female mice were 
used for embryo collection, and 12 C57Bl/6J males were used as studs (only copulated with females to 
fertilize the eggs). Nine NMRI females were used as surrogate mothers.  All animal procedures were 
made under rigorous standards of animal welfare and complied with the Directive 2010/63/EU 
(European Parliament and the Councli pf the European Union, 2010).  
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Figure 21 – Mice embryo Microinjection Chamber 
 C57BL/6J females were superovulated with 5IU PMSG (Sigma) at 2p.m. and 46 hours after 
with 5IU hCG (Sigma) and mated with C57BL/6J males right after hCG administration via intra-
peritoneal injection. 16-18 hours after, females were sacrificed and oocytes collected into a 
hyaluronidase medium (Sigma), to degrade the cumulus cells. After cumulus cells degradation, 
embryos were washed in M2 and M16 medium (Sigma) and left incubate at 37ºC, 5%CO2 for 3h.  
Microinjection needles and microinjection set-up 
 
Fertilized oocytes, checked by the presence of pronuclei, were chosen under a Zeiss Discovery 
V8 scope. Microinjection of embryos was performed with a Zeiss Observer Z1 microscope adapted to 
microinjection with Eppendorf Transfer Man NK2 micromanipulator and Eppendorf FemtoJet 
Microinjector. Capillaries from WPI (Thin wall single- barrel Standard Borosilicate 1mm with 
filament) were pulled on a Sutter P-2000 needle puller, to produce microinjection needles. Holding 
needles were bought from Eppendorf (VacuTip). Microinjection needles were loaded with Eppendorf 
Microloader™ tips. 
 
Embryo Microinjection  
 
After 3h, fertilized embryos were transferred into a microinjection chamber (Fig. 21), 
consisting on a drop of M16 medium covered with paraffin oil (Sigma). Embryos were microinjected 
in the pronuclei with a continuous flow from Eppendorf FemtoJet microinjector. Different 
concentrations were tested, first only the tyrosinase guide 1 was co-injected, at a concentration of 
20ng/μl, with Cas9 protein at 100ng/μl. Next, the 2 guides were co-injected, 20 ng/μl each, with 
100ng/μl Cas9 protein. Lastly, the 2 guides were co-injected, 50 ng/μl each, with 60 ng/μl Cas9 
protein. 
Right after injection, embryos were transferred into a surrogated mother, if primed surrogated 
mothers were not available for the day of embryo microinjection, embryos were incubated until 2-cell 
stage and then transferred to a surrogated mother or frozen. NMRI females were used as surrogated 
mothers and a maximum of 40 embryos were transferred to a single female. Twenty-one days after 
pups were born.   
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Table 7: PCR cycle for tyrosinase guide 1 indels (A) and PCR cycle for tyrosinase guide 2 indels (B) 
Screening for mutations  
 
This case is identical to the zebrafish tyrosinase mutation. Animals were expected to have a 
lack of pigmentation in the coat colour, this phenotype should be visible in 5-day-old pups, when 
pigmentation starts to appear.  About 21 days after pups were born, they can be weaned and an ear 
sample can be taken to genotype and search for indels.  
 
Primers  
 
Primer design was done using NCBI primer Blast and OligoPerfectTM Designer (Thermo 
Fisher Scientific). Primers can be found in Appendix 5. For tyrosinase guide 2 a first design pair of 
primers (amplification of ~340bp) was not functional and a new pair was designed but was not 
possible to amplify a smaller fragment, being the new amplicon of ~544 bp, not a perfect size to found 
indels.  
 
DNA extraction  
 
All DNA extractions of ear samples were performed with REDExtract-N-AmpTM Tissue PCR 
Kit. PCR reaction mix for the tyrosinase guide 1 indels was also performed using REDExtract-N-
AmpTM Tissue PCR Kit in a 25 μl reaction mix. But for tyrosinase guide 2, REDextraction reagents to 
PCR didn’t work. This amplification was performed with Dream taq PCR Master Mix and a small 
modification in the PCR cycle. After PCR reactions, samples were loaded into a 3% agarose gel or in 
QIAxcel ScreenGel®.  
 
 
 
Initial Denaturation 95°C 30 seconds
95°C 30 seconds
58°C 30 seconds
68°C 2 minute
Final Extension 72°C 5 minutes
Hold 12ºC
Temperature
34 Cycles
Time
Initial Denaturation 95°C 30 seconds
95°C 30 seconds
58°C 30 seconds
68°C 2 minute
Final Extension 72°C 5 minutes
Hold 12ºC
Time
38 Cycles
TemperatureA B 
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Table 8 Mouse microinjection concentrations of guideRNA and Cas9 protein; embryo 
survival rates and number of born pups 
6.2 Results  
 
Production of guide RNA 
 
After annealing the oligos and fill-in with T4 polymerase, template was purified using a PCR 
column (QIAquick PCR Purification Kit) and eluted in 30 μl of water. Concentration of DNA was 
expected to be between 100-200ng/μl, tyrosinase guide 1 template was 190 ng/μl and tyrosinase guide 
2 was 165 ng/μl. Template was then loaded into a 1% agarose gel, a band of ~120bp was observed 
(Fig. 20) (as described in protocol). 
RNA extracted from tyrosinase guide 1 with Phenol/chloroform was 1700 ng/ μl. According 
to the ratios of the absorbance parameters and by applying the Beer-Lambert Law, guideRNA was 
contaminated with protein (A260nm/A280nm = 1.59) but free from organic contaminants (A260nm/A230nm = 
2.44). RNA extracted from tyrosinase guide 2 with Phenol/chloroform was 1683 ng/ μl. According to 
the ratios of the absorbance parameters and by applying the Beer-Lambert Law, guideRNA was free 
from protein contaminants (A260nm/A280nm = 2.03) and free from organic contaminants (A260nm/A230nm = 
2.03). 
 
Screening for mutations 
 
 In total, 41 animals were born from microinjection (See Appendix 6 for mix concentrations 
and survival rates). None of these animals showed lack of pigmentation, being identical to wildtype 
animals.  Some lack of pigmentation in the tail was found, but a similar pattern was also found in 
wildtype mice, so that phenotypic result was discarded.  
 
 
 
 
Genotyping 
 
Two different PCR reactions were performed (Table 6), one for tyrosinase guide 1 injection 
indels screening (Fig. 23), expected size of ~200bp, and another one for tyrosinase guide 2, expected 
size of ~544 bp. All samples from guide 1 injected pups amplified a single band of ~200 bp around the 
tyrosinase guide 1 target site, just like the wildtype control sample. These results point to a lack of 
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Figure 22 -  Amplification of genomic DNA from tyrosinase guide 2 injected animals for 
screening tyrosinase guide 2 indels. Ladder: GeneRuler 200bp (1) WT control sample (2). 
 
efficiency of tyrosinase guide 1. Likewise, all samples from tyrosinase guide 2 injected pups amplified 
a single band of ~544 bp around the guide 2 target site, just like the wildtype control sample (Fig. 22). 
Again, these results point to a lack of efficiency of tyrosinase guide 2.  
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7. General Discussion 
 
In this project, our main objective was to establish a unique protocol for guideRNA production 
and CRISPR knockout generation that would fit all three organisms currently used in CF: Danio rerio, 
Drosophila melanogaster and Mus musculus. Our starting point was the reproduction of the protocol 
of Gagnon et. al (2014), that is a well-established for mutant production using CRISPR/Cas9, in 
zebrafish followed by its adaptation to the two other model species. In order to achieve this goal, 
production of tyrosinase mutant zebrafish through Gagnon et.al (2014) protocol was achieved. After 
establishment of this technique in zebrafish, production of tyrosinase knockout in mice and yellow 
knockout in fruit fly was tested. 
 In zebrafish, we were able to reproduce the protocol and produce a tyrosinase knockout 
animal. But, some steps of the protocol were not reproducible. First, RNA extraction with Qiagen 
micro-RNA purification Kit had a very low yield. Concentrations extracted were, most of the times, 
not enough for embryo microinjection, probably due do column saturation. The chosen alternative 
method was RNA extraction with Phenol/chloroform. The guideRNA extracted this way, was effective 
in knocking out tyrosinase gene although the absorbance parameters showed a slight protein 
contamination (A260nm/A280nm = 1.66). We have failed to amplify a tyrosinase fragment for genotyping 
when using genomic DNA extracted from embryos. However, we showed that the extraction protocol 
worked for amplification of other amplicons and that the tyrosinase primer pair also worked when the 
template was extracted from later stage larvae or adults. When added DMSO, amplification was 
observed and since tyrosinase gene starts to be transcribed 16.5 hpf (Camp et al., 2001), this problem 
that we encountered must be due to a technical problem of little genomic DNA and PCR optimization. 
Another aspect, probably due to fast embryo development, is the mosaicism encountered. It was 
expected that knocking out tyrosinase would lead to lack of pigmentation. However, a mosaic lack of 
pigmentation occurs. This means that some cells were tyrosinase knockout but others were not, the 
bigger the number of targeted cells, the bigger the number of non-pigmented areas in the animal. In 
some extreme cases, we found some individuals with almost all cells pigmented except for a stripe in 
the eye. These individuals were probably injected in a slightly later stage in comparison to the others. 
This mosaic phenotype is in accordance with Ablain et al (2015), where a mosaic gene disruption also 
occurred (Ablain et al., 2015). For mutation to occur, the CRISPR machinery (guideRNA and Cas9 
protein), have to be in the cell nucleus. We would only have a clonal mutant animal if the errors were 
induced right before the first mitosis. However, as initial stages of development are very fast, that 
developmental windows are very narrow. To add to the speed of the initial cell divisions, we also have 
to consider the dynamics of the CRISPR machinery itself. It seems thus possible that CRISPR-induced 
mutations will only occur at a later developmental stage, when mitosis has slowed down, and only in 
cells that still have the machinery available. For this last point we have to consider, not only the half-
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life of the machinery components, but also the dilution and potentially asymmetrical distribution of 
this components from cell to cell. What follows from these arguments is that the later the injection, the 
less likely it is that all cells receive the CRISPR components necessary for DSBs and mutant 
generation, and less mutant cells the animal will have. Additionally, as cell division continues, the 
more diluted the CRISPR components will be in each cell and the less likely the DSBs and induced 
mutations. This mosaic phenotype is represented in our genotyping results, where each individual 
shows different mutations. In F1 animals, this phenotypic mosaicism disappears because they are 
derived from the gametes and contribution of only 1 allele from each mosaic parent, but not the gene 
disruption mosaicism, as seen in genotyping of F1 results, where the wildtype band disappears but 
different band sizes are still amplified, meaning that continues to be a mosaic. To get rid of this 
mosaicism outcross matings with wildtype animals need to be performed until a stock is established. 
However, the protocol that we followed showed to be efficient in zebrafish where a tyrosinase gene 
knockout occurred.   
In fruit fly we were not able to reproduce the Gagnon et.al (2014) CRISPR components 
delivery protocol, namely co-injection of guideRNA and protein Cas9. In particular, for the delivery of 
Cas9 protein, the injection concentration of this component had to be higher than the concentration of 
our stock Cas9 protein solution (Lee et al., 2014). As we did not have any reliable protocol for protein 
concentration at our disposal, this limitation could only be circumvented by de novo protein synthesis, 
which was not an option within the scope of this thesis. There are alternative CRISPR components 
delivery methods in the fly system, which should be explored in future work. It has been shown that 
microinjection of in vitro synthetize guideRNA is more efficient than injection of a guideRNA 
encoding plasmid (Bassett et al., 2013; Gratz et al., 2014) but, these efficiency is accompanied with 
injection of a Cas9mRNA encoding plasmid and of Cas9 protein.  An alternative source of Cas9 
delivery is the use of Cas9-transgenic flies. In this case, the fly is expressing Cas9 protein and only in 
vitro synthetized guideRNA is microinjected into the fly embryo. The two main disadvantages of 
using Cas9 flies are: the fact that the possibility of targeting any fly line is removed and that after 
production of mutant flies it is needed to remove the Cas9 transgene. Both disadvantages can be 
overcome by prior or after additional crosses. In the first case, one should first cross the fly line of 
interest to transgenic Cas9 flies establishing a stable stock and only after inject guideRNA to target 
mutation. In the latter case, additional crosses should be made after to eliminate the Cas9 transgene in 
the final mutated stock. Using Cas9 transgenic flies increases the efficiency of CRISPR/Cas9 
technique (Port et al., 2015). Different transgenic Cas9 flies are already available and stocks differ in 
expression patterns, activity and chromosomes carrying the transgene. Using vas-cas9 (Bl #51324) 
flies, as an alternative to Cas9 protein injection, solves the Cas9 protein stock low concentration 
problem. However, we have to bear in mind that the Cas9 transgene in this particular stock is 
positively marked with a yellow+ gene, turning the screening of yellow mutants more complicated, only 
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possible in F2 animals and beyond the temporal scale of this thesis. Alternatively, and for future work, 
we can also make use of other Cas9-expressing stocks that are neither in a yellow background nor 
bearing a yellow+ marked Cas9 transgene. Such stocks exists but are not available at common stock 
centres for purchasing and can only be acquired by establishment of collaborations.  
 Regarding mouse tyrosinase gene knockout, we injected 2 guideRNAs, targeting different 
regions of the gene: one near the ATG site and a second one that was further down the coding region 
but with a higher score in the software tool used. No phenotypic results were visible and genotyping 
F0 results were in accordance with this observation. One possibility to explain the failure of tyrosinase 
knockout mice generation can be the protocol that we were following, that it was optimized for fish 
CRISPR/Cas9 target mutagenesis. To address that, a protocol directed to mice CRISPR/Cas9 target 
mutagenesis should be followed with the same guideRNA sequence. For example, in Henao-Meija et 
al. (2017) protocol, guideRNA production consists also in the annealing of two oligos, one with the 
guideRNA desired and another one with T7 promotor sequence. Another possibility is that the target 
mutagenesis occurred, but the induced mutations did not produce a visible phenotype and indels were 
just 1-2bp long and beyond the separation limit of the Qiaxcell gel. This possibility could be tested be 
using and alternative genotyping method, in particular, the T7 endonuclease assay (NEB). T7 
endonuclease recognizes and cleaves non-perfectly matched DNA or heteroduplexes. The T7 cleaved 
sample can be easily run in an agarose gel and would show 2 bands if a mutation had occurred (Dad et 
al., 2014). 
 Challa et.al (2016) used the same targeting strategy as us in this project, actually one of the 
used guide was just 2 nucleotides different from ours tyrosinase guide 1.  In their experiments, the 
injected embryos were C57Bl/6J bred to albino Tyr C57Bl/6J. The tyrosinase mutation is recessive, 
meaning that both alleles have to be mutated to result in a phenotypically albino animal. By doing 
injections in heterozygous embryos, they could easily identify animals in which the DSBs and loss-of-
function mutations only occurred in one allele. They had two black animals out of thirteen positive 
born animals that had indel mutations. One way of increasing knockout efficiency is augmenting the 
deletion size and that can be achieved by co-injecting two guideRNAs (Lin et al., 2014). However, in 
Challa et al. (2016) work this proved to be a very rare event. We don’t have any reason to doubt that 
the protocol used in this thesis does not work -  microinjection of in vitro synthetized guideRNA in 
and Cas9 protein is a technique already established for the mouse model. (Harms et al., 2014; Henao-
Mejia et al., 2016; Ma et al., 2017; Thermo Fisher Scientific, n.d.). Animals born from this master 
thesis need to be further tested to conclude if they bear no mutations.  
 Overall, further work needs to be done, in particular regarding Drosophila and mouse mutant 
screening. Addressing if a mutation occurs but it’s being overcome by wildtype cells. Either way, 
establishing an easier and more efficient protocol for CRISPR/Cas9 targeted mutagenesis in zebrafish 
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was one of the main objectives of this project and it was accomplished being used for different target 
genes now at the CF Fish Facility. 
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8. General Conclusions 
 
With this project, we made a proof of principle of an existing protocol for guideRNA 
production with consequent production of mutant zebrafish. We can conclude that the protocol is easy 
to follow and less time consuming than other CRISPR guideRNA production protocols, which are two 
key features.  Also, it is cheaper since there is no need to clone vectors. Regarding RNA extraction 
after transcription, we conclude that phenol/chloroform is more efficient in RNA extraction and 
cheaper that Qiagen micro-RNA extraction kit. Even though guideRNA was slightly contaminated 
with protein it was still efficient in producing DSB in tyrosinase gene in zebrafish. 
We conclude that DNA extraction from zebrafish embryos works but for tyrosinase gene in 
specific, more extraction and PCR optimization are needed.   
We can also conclude that a single guideRNA is sufficient to knockout a gene through NHEJ 
cell repair. Also, NHEJ can produce different mutations with the exact same DSB break, producing 
different knockout animals. Also, even in the individual itself, there is mosaic gene disruption. 
In the work done with fruit fly we can conclude that microinjection of Cas9 protein requires a 
huge concentration, confirming other results already in literature.  
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Name Cas9 Protein sgRNA Dead after injection Alive (24h after) Alive (48h after) % survival (24h after)
 Laying 1 102 28 21,54%
Control laying  1 27 15 35,71%
Laying 2 13 46 77,97%
Control laying 2 4 30 88,24%
 Laying 3 72 95 56,89%
Control laying  3 14 55 79,71%
 Laying 4 34 28 45,16%
Control laying  4 1 79 98,75%
 Laying 5 60 17 22,08%
Control laying  5 14 9 39,13%
 Laying 6 33 82 71,30%
Control laying  6 3 72 96,00%
 Laying 7 27 58 68,24%
Control laying  7 16 55 77,46%
 Laying 1 90 129 58,90%
Control laying  1 95 137 59,05%
 Laying 2 140 98 41,18%
Control laying  2 84 75 47,17%
 Laying 3 26 64 71,11%
Control laying  3 50 141 73,82%
 Laying 4 61 79 56,43%
Control laying 4 34 92 73,02%
 Laying 5 20 91 81,98%
Control laying 5 23 110 82,71%
Laying 1 99 128 32 56,39%
Control laying 1 109 112 50,68%
Laying 2 76 32 37 29,63%
Control laying 2 137 65 32,18%
Laying 3 102 60 69 37,04%
Control laying 3 43 32 42,67%
Laying 1.1 39 43 52,44%
Laying 1.2 62 73 54,07%
Laying 1.3 35 38 52,05%
Control laying 1 (all) 20 27 57,45%
Laying 2 93 145 60,92%
Control Laying 2 56 75 57,25%
Laying 1 75 208 73,50%
Control laying 1 34 79 69,91%
Laying 2 90 287 76,13%
Control laying 2 41 99 70,71%
Microinjection 5
315 ng/ul 526 ng/ul
526 ng/ul315 ng/ul
Microinjection 4
315 ng/ul 526 ng/ul
600 ng/ul 200 ng/ul
Microinjection 3
500 ng/ul 437,7 ng/ul
500 ng/ul 437,7 ng/ul
437,7 ng/ul500 ng/ul
437,7 ng/ul
260 ng/ul
260 ng/ul
260 ng/ul
260 ng/ul
260 ng/ul 437,7 ng/ul
437,7 ng/ul
437,7 ng/ul
437,7 ng/ul
Microinjection 1
Microinjection 2
260 ng/ul 173.9 ng/ul
260 ng/ul 173.9 ng/ul
173.9 ng/ul260 ng/ul
260 ng/ul
260 ng/ul
260 ng/ul
260 ng/ul
173.9 ng/ul
173.9 ng/ul
173.9 ng/ul
173.9 ng/ul
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Appendix 1 - Danio rerio embryo microinjection survival rates and concentration injected of 
guideRNA and Cas9 protein  
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Cas9 protein (ng/ul) sgRNA (ng/ul)
300 250
500 250
800 250
800 500
Tyr_Fwd GCGTCTCACTCTCCTCGACTCTTC
Tyr_ Rv GTAGTTTCCGGCGCACTGGCAG
Yellow_Fwd ATACAGCTGGAGATTGCGCCA
Yellow_Rv CCAGGTAGCTCGTATCTCCGAATT
Tyr1mouse_Fwd TGGCAAAAGAATGCTGCCC
Tyr1mouse_Rv AACCCATGAAGTTGCCTGAG
Tyr2mouse_Fwd ATGAAGCACCAGGGTTTCTG
Tyr2mouse_Rv GAGCGGTATGAAAGGAACCA
Appendix 2 – Overall table results QIAxcel ScreenGel®, from indels screening of F0 injected 
zebrafish animals for tyrosinase knockout 
 
 
 
Appendix 3 – Drosophila embryos microinjection mixes concentrations  
 
 
 
 
 
Appendix 4 – Primers table  
 
 
 
 
 
 
